PUMA BIOTECHNOLOGY, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $20.7M | $20.7M | $0 | $32.6M |
| FY2022 | $-15.8M | $-15.8M | $0 | $11.8M |
| FY2023 | $27.0M | $26.9M | $140.0K | $10.2M |
| FY2024 | $38.9M | $38.9M | $56.0K | $8.2M |
| FY2025 | $41.8M | $41.7M | $71.0K | $6.9M |